Journal
NATURE BIOTECHNOLOGY
Volume 30, Issue 12, Pages 1191-1197Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2437
Keywords
-
Categories
Funding
- American Society of Clinical Oncology (ASCO)
- American College of Rheumatology (ACR)
- American Association of Liver Diseases (AASLD)
- American Heart Association (AHA)
- American Society of Hematology (ASH)
- Biotechnology Industry Association (BIO)
Ask authors/readers for more resources
Sales in the biologics sector show modest but healthy growth rates for the fourth consecutive year, with cancer drugs garnering the greatest revenues. As the diabetes epidemic grows and innovation of insulins continues, drug companies in that space are moving up in the ranks.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
